Advertisement
U.S. markets close in 1 minute
  • S&P 500

    5,256.83
    +8.34 (+0.16%)
     
  • Dow 30

    39,819.86
    +59.78 (+0.15%)
     
  • Nasdaq

    16,384.46
    -15.06 (-0.09%)
     
  • Russell 2000

    2,121.38
    +7.03 (+0.33%)
     
  • Crude Oil

    82.99
    +1.64 (+2.02%)
     
  • Gold

    2,241.10
    +28.40 (+1.28%)
     
  • Silver

    24.98
    +0.23 (+0.92%)
     
  • EUR/USD

    1.0791
    -0.0039 (-0.36%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2622
    -0.0016 (-0.13%)
     
  • USD/JPY

    151.3730
    +0.1270 (+0.08%)
     
  • Bitcoin USD

    70,868.81
    +2,145.96 (+3.12%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Gilead Sciences: Living with a Rare Blood Cancer: Marion’s Story

NORTHAMPTON, MA / ACCESSWIRE / June 7, 2023 / Marion grew up very healthy, never even getting colds or the flu - but that changed as she got older.

In her late 50s, Marion's doctor found a cancerous wart that required an intense six weeks of radiation therapy, coupled with chemotherapy. Then nearly five years later, she was diagnosed with myelodysplastic syndrome (MDS), a rare form of blood cancer that often occurs in people previously treated with radiation or chemotherapy.

A stem cell transplant is usually key to surviving MDS, but due to Marion's age and chronic conditions, she wasn't a good candidate for a transplant. Instead, her hematologist put her on a medication and she responded well.

Today Marion visits her doctor every four weeks for blood testing and has been treatment-free for more than 18 months.

"I don't look back," she says of her experience. "The disease does not define me. I am still me."

Originally published by Gilead Sciences

Gilead Sciences, Wednesday, June 7, 2023, Press release picture
Gilead Sciences, Wednesday, June 7, 2023, Press release picture

View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.

Contact Info:
Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: info@3blmedia.com

SOURCE: Gilead Sciences



View source version on accesswire.com:
https://www.accesswire.com/759805/Gilead-Sciences-Living-with-a-Rare-Blood-Cancer-Marions-Story

Advertisement